Document is current
Any future updates will be listed below
-
Authors
Neumann, Manuela
Perneel, Jolien
Cheung, Simon
Van den Broeck, Marleen
Nygaard, Haakon
Hsiung, Ging-Yuek R.
Wynants, Sarah
Heeman, Bavo
Rademakers, Rosa
Mackenzie, Ian R. A. https://orcid.org/0000-0003-3875-2972
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (74580)
National Institute on Aging (UAG063911)
Universiteit Antwerpen
Foundation for the National Institutes of Health (UG3 NS103870)
- License Information
-
More Information
Article History
Received: 13 March 2023
Revised: 25 April 2023
Accepted: 25 April 2023
First Online: 12 May 2023
Declarations
:
: Dr. Rademakers is a member of the Scientific Advisory Board of Arkuda Therapeutics and receives invention royalties from a patent related to progranulin. Dr. Mackenzie is a member of the Scientific Advisory Board of Prevail Therapeutics and receives invention royalties from a patent related to progranulin.
